Metraipolis › archive › dc_983b0ead2eb8

Clinically oriented immune heterogeneity in prostate cancer: emerging targets and strategies — Europe PMC PMID:41766852

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41766852
DOI
10.3389/fimmu.2026.1753718
License (as archived)
solo-consultazione
Archived
2026-11-05T21:48:49.381Z
SHA-256 of the archived text
59d3f2951c983db7ee6168292e4eb3233c49f1b87de00d14e19903eb874a7411
Stable URL of this page
https://metraipolis.com/documento/dc_983b0ead2eb8

How to cite

Clinically oriented immune heterogeneity in prostate cancer: emerging targets and strategies — Europe PMC PMID:41766852 — Europe PMC (en), https://europepmc.org/article/MED/41766852 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_983b0ead2eb8 (Metraipolis archive dc_983b0ead2eb8, sha256 59d3f2951c983db7ee6168292e4eb3233c49f1b87de00d14e19903eb874a7411)
BibTeX
@misc{dc983b0ead2eb8,
  title = {Clinically oriented immune heterogeneity in prostate cancer: emerging targets and strategies — Europe PMC PMID:41766852},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41766852},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_983b0ead2eb8; sha256 59d3f2951c983db7ee6168292e4eb3233c49f1b87de00d14e19903eb874a7411},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41766852. Agents can read the archived copy with the MCP tool read_document.